FTSE 100 news / Companies and sectors / Smith & Nephew / 13 October 2026

Smith & Nephew (SN): news on Tuesday 13 October 2026

+1.7 slightly positive

Coverage was mixed: the Xodus Medical acquisition to broaden its portfolio was positive, while analysts trimmed their price target and commentary asked whether the shares can rebound ahead of the next trading update.

What drove it

Xodus Medical acquisition
analyst target cut
upcoming trading update

The 3 stories

Each headline's own score, strongest first. Links go to the publisher.

+8.7 Smith & Nephew Acquires Xodus Medical to Enhance Product Portfol GuruFocus
Acquisition of Xodus Medical expands product portfolio.
−4.7 Analysts cut target for Smith+Nephew stock to GBp 1,257.00 from GBp 1,291.00 - ad-hoc-news.de ad-hoc-news.de
Analysts lowered price target modestly, a mild negative signal.
−0.8 Can Smith & Nephew (LSE:SN.) Stock Rebound As Its Next Trading Update Nears? Kalkine Media
Speculative preview of trading update; stock has fallen, outcome uncertain.

Smith & Nephew: every day · Pharma and healthcare on 13 October 2026 · FTSE 100 overview for the day